2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow SCY-635: new trials by email Literature Review of SCY-635 trials Research Report on SCY-635
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of SCY-635, Pegasys and Copegus in Hepatitis C Placebo, SCY-635, Pegasys - Hepatitis C Infection | Phase 2 | Completed | Scynexis, Inc. | 10 | 2010-11-01 | 2017-08-18 |
| Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients Placebo, SCY-635 - Chronic Hepatitis C | Phase 1 | Completed | Scynexis, Inc. | 57 | 2007-04-01 | 2014-11-06 |
Hepatitis C (1) · Hepatitis C, Chronic (1)
Scynexis, Inc. (2)
United States (2) · Puerto Rico (1)
Andrew J Muir, MD (1) · Douglas Heuman, MD (1) · Jacob Lalezari, MD (1) · Keyur Patel, MD (1)